Use of Traditional Chinese Medicine in Chinese Patients with Coronary Heart Disease

被引:26
作者
Guo Xiang Yu [1 ]
Liu Jing [1 ]
Liu Jun [1 ]
Li Hong Juan [1 ]
Qi Yue [1 ]
Qin Lan Ping [1 ]
Wang Miao [1 ]
Zhao Dong [1 ]
机构
[1] Capital Med Univ, Beijing Anzhen Hosp, Beijing Inst Heart Lung & Blood Vessel Dis, Beijing 100029, Peoples R China
关键词
Traditional Chinese medicine; Coronary heart disease; Guidelines; ACUTE MYOCARDIAL-INFARCTION; SECONDARY PREVENTION; CARDIOVASCULAR-DISEASES; ARTERY-DISEASE; METAANALYSIS; PROJECT; SAFETY; DRUGS;
D O I
10.3967/0895-3988.2013.04.009
中图分类号
X [环境科学、安全科学];
学科分类号
083001 [环境科学];
摘要
Objective To study the use of traditional Chinese medicine (TCM) or both TCM and guideline-recommended Western medicine (WM) in Chinese patients with coronary heart disease (CHD). Methods A cross-sectional nationwide survey of 2803 CHD outpatients was completed by collecting information, including general demographic data, disease history, and use of drugs (including TCM and WM). Results Of the 2712 CHD outpatients with complete drug treatment data, only 3.1% received TCM without any WM for CHD, 30.0% received both TCM and WM recommended by current CHD guidelines, and 66.9% received only WM. Patients with a longer history of CHD or with a history of stroke, were more likely to use TCM. However, 90.6% of CHD patients who used TCM also used certain WM. Furthermore, patients who used more types of TCM tended to use much less WM recommended by current guidelines. Conclusion A substantial proportion of Chinese CHD outpatients use both TCM and WM for secondary prevention of CHD. It is important to assess the effect of combined TCM and WM on major clinical outcomes in Chinese CHD patients.
引用
收藏
页码:303 / 310
页数:8
相关论文
共 46 条
[1]
[Anonymous], MODERN TRADIT CHIN M
[2]
[Anonymous], J CARDIOVASC PULM DI
[3]
Chan E, 2010, CURR OPIN DRUG DISC, V13, P50
[4]
Chen H, 2009, CHINESE J INTEGRATED, V7, P379
[5]
XS0601 reduces the incidence of restenosis:: a prospective study of 335 patients undergoing percutaneous coronary intervention in China [J].
Chen, KJ ;
Shi, DZ ;
Xu, H ;
Lü, SZ ;
Li, TC ;
Ke, YN ;
Zhang, MZ ;
Lu, XY ;
Sun, RY ;
You, SJ .
CHINESE MEDICAL JOURNAL, 2006, 119 (01) :6-13
[6]
Chen Yuh-Fung, 2012, Front Biosci (Elite Ed), V4, P809, DOI 10.2741/E420
[7]
Cardiovascular effects of Danshen [J].
Cheng, Tsung O. .
INTERNATIONAL JOURNAL OF CARDIOLOGY, 2007, 121 (01) :9-22
[8]
Chu FY, 2010, CHINESE J INTEGRATIV, V16, P301
[9]
Meta-analysis: Secondary prevention programs for patients with coronary artery disease [J].
Clark, AM ;
Harding, L ;
Vandermeer, B ;
McAlister, FA .
ANNALS OF INTERNAL MEDICINE, 2005, 143 (09) :659-672
[10]
Safety of Herbal Supplements: A Guide for Cardiologists [J].
Cohen, Pieter A. ;
Ernst, E. .
CARDIOVASCULAR THERAPEUTICS, 2010, 28 (04) :246-253